Citizens Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $525K | Buy |
3,111
+1
| +0% | +$171 | 0.01% | 529 |
|
|
2025
Q4 | $525K | Sell |
3,110
-276
| -8% | -$44.8K | 0.01% | 529 |
|
|
2025
Q3 | $489K | Buy |
3,386
+437
| +15% | +$59.6K | 0.01% | 538 |
|
|
2025
Q2 | $373K | Buy |
2,949
+211
| +8% | +$25.9K | 0.01% | 534 |
|
|
2025
Q1 | $350K | Sell |
2,738
-51
| -2% | -$6.92K | 0.01% | 475 |
|
|
2024
Q4 | $369K | Buy |
2,789
+808
| +41% | +$114K | 0.01% | 442 |
|
|
2024
Q3 | $288K | Buy |
+1,981
| New | +$287K | 0.01% | 471 |
|
|
2023
Q1 | – | Sell |
-2,086
| Closed | -$274K | – | 466 |
|
|
2022
Q4 | $274K | Hold |
2,086
| – | – | 0.01% | 350 |
|
|
2022
Q3 | $244K | Sell |
2,086
-180
| -8% | -$22.4K | 0.01% | 359 |
|
|
2022
Q2 | $267K | Hold |
2,266
| – | – | 0.01% | 365 |
|
|
2022
Q1 | $295K | Hold |
2,266
| – | – | 0.01% | 367 |
|
|
2021
Q4 | $346K | Sell |
2,266
-165
| -7% | -$25.5K | 0.01% | 347 |
|
|
2021
Q3 | $393K | Sell |
2,431
-75
| -3% | -$12.6K | 0.01% | 317 |
|
|
2021
Q2 | $410K | Sell |
2,506
-1,599
| -39% | -$246K | 0.02% | 263 |
|
|
2021
Q1 | $618K | Hold |
4,105
| – | – | 0.03% | 193 |
|
|
2020
Q4 | $622K | Hold |
4,105
| – | – | 0.04% | 178 |
|
|
2020
Q3 | $556K | Sell |
4,105
-210
| -5% | -$28.5K | 0.04% | 172 |
|
|
2020
Q2 | $590K | Hold |
4,315
| – | – | 0.04% | 173 |
|
|
2020
Q1 | $465K | Buy |
4,315
+72
| +2% | +$8.29K | 0.04% | 189 |
|
|
2019
Q4 | $511K | Sell |
4,243
-475
| -10% | -$53K | 0.03% | 181 |
|
|
2019
Q3 | $469K | Sell |
4,718
-225
| -5% | -$23.6K | 0.03% | 175 |
|
|
2019
Q2 | $540K | Buy |
4,943
+70
| +1% | +$7.45K | 0.04% | 166 |
|
|
2019
Q1 | $545K | Buy |
4,873
+91
| +2% | +$9.98K | 0.04% | 166 |
|
|
2018
Q4 | $462K | Hold |
4,782
| – | – | 0.04% | 155 |
|
|
2018
Q3 | $584K | Sell |
4,782
-861
| -15% | -$101K | 0.05% | 151 |
|
|
2018
Q2 | $620K | Buy |
5,643
+429
| +8% | +$45.9K | 0.05% | 147 |
|
|
2018
Q1 | $557K | Sell |
5,214
-45
| -0.9% | -$4.99K | 0.05% | 156 |
|
|
2017
Q4 | $562K | Sell |
5,259
-150
| -3% | -$16K | 0.05% | 155 |
|
|
2017
Q3 | $601K | Sell |
5,409
-330
| -6% | -$35.3K | 0.05% | 146 |
|
|
2017
Q2 | $593K | Sell |
5,739
-45
| -0.8% | -$4.43K | 0.05% | 147 |
|
|
2017
Q1 | $566K | Sell |
5,784
-507
| -8% | -$48.5K | 0.05% | 150 |
|
|
2016
Q4 | $557K | Sell |
6,291
-1,080
| -15% | -$98.3K | 0.05% | 151 |
|
|
2016
Q3 | $712K | Sell |
7,371
-1,374
| -16% | -$131K | 0.07% | 139 |
|
|
2016
Q2 | $750K | Sell |
8,745
-56,928
| -87% | -$5.11M | 0.07% | 132 |
|
|
2016
Q1 | $5.71M | Buy |
65,673
+4,479
| +7% | +$401K | 0.55% | 72 |
|
|
2015
Q4 | $7.4M | Buy |
+61,194
| New | +$6.64M | 0.7% | 60 |
|
Other funds holding IBB
CB
Citizens Financial Group's IBB Position: Q1 2026 in Review
Citizens Financial Group increased its iShares Biotechnology ETF (IBB) stake by 0.03% in Q1 2026, buying an estimated $171 and bringing the position to 3,111 shares worth $525K. The position accounts for 0.01% of the portfolio, ranked #529.
Citizens Financial Group first reported a position in IBB in Q4 2015 and has held it in 36 quarters since. The position peaked at $7.4M in Q4 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Citizens Financial Group held 3,111 shares of iShares Biotechnology ETF worth $525K as of Q1 2026.
- Citizens Financial Group bought 1 iShares Biotechnology ETF share in Q1 2026, an estimated $171.
- iShares Biotechnology ETF made up 0.01% of Citizens Financial Group's portfolio in Q1 2026, its #529 holding.
- Citizens Financial Group first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 36 quarters since.
- Citizens Financial Group's iShares Biotechnology ETF position peaked at $7.4M in Q4 2015.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.